drug: dexmethylphenidate

Clinical class	anorexiant, antinarcoleptic, psychostimulant, (amphetamine-like)
Action	sympathomimetic amine, central nervous system stimulant
Chemical class	active d-threo-enantiomer of methylphenidate
CSA schedule	II
DEA number	none
Routes of administration	oral
Associated with (substance-related)	disorders
Availability	prescription

Focalin™ (Novartis) FDA approved for treatment of : Attention Deficit Hyperactivity Disorder (ADHD) 11.13.2001
U.S. Prescribing information
Focalin XR™ (Novartis) FDA approved for treatment of : Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older 5.26.2005
U.S. Prescribing information